/DISREGARD RELEASE: YS Biopharma/
{window.open('https://sns.qzone.qq.com/cgi-bin/qzshare/cgi_qzshare_onekey?url='+encodeURIComponent(location.href)+'&title='+encodeURIComponent(document.title)+'&summary=&desc=&pics=https://static.prnasia.com/pro/pcom/includes/images/logo-prn-02_PRN.png','_blank','width=650,height=450');})()){kind=link}
We are advised by YS Biopharma Co., Ltd. (NASDAQ:YS) that journalists and other readers should disregard the news release, "YS Biopharma Co., Ltd. to Hold Extraordinary General Meeting on December 28, 2023", issued on December 20, 2023 by YS Biopharma over PR Newswire, as the release contained erroneous information.
Source: YS Biopharma
Related stocks: NASDAQ:YS
Featured Video
Recent Releases
- YS Biopharma Receives Additional 180 Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule
- YS Biopharma Receives Additional 180 Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule
- YS Biopharma Announces Unaudited Financial Results for the First Nine Months of Fiscal Year 2024
- YS Biopharma Granted Phase I Clinical Trial License of Therapeutic Chronic Hepatitis B Virus Vaccine
- YS Biopharma to Report First Nine Months of Fiscal Year 2024 Financial Results on April 19, 2024
- YS Biopharma Announces Positive Interim Results of Pivotal Phase 3 Clinical Study of PIKA Rabies Vaccine
- Go to MediaRoom
Biotechnology Recent Releases
- Clarivate Introduces Epidemiology Intelligence™ for Precision Patient Population Analysis
- Sciwind Biosciences and HK inno.N Corporation Announce Licensing and Partnership Agreement for Ecnoglutide Injection (XW003) in South Korea
- GC Genome to Present New Clinical Data on Colorectal Cancer Detection at the ASCO Annual Meeting 2024
- Innovent Receives NMPA Breakthrough Therapy Designation for IBI343（Anti-Claudin18.2 ADC）as Monotherapy for Advanced Gastric Cancer
- HTL Biotechnology, market leader in biopolymers, acquires the Modern Meadow's human recombinant collagen platform for beauty and biomedical applications
- Read more
Computer/Electronics Recent Releases
- ICICI Bank enables NRI customers to use international mobile number to make UPI payments in India
- Sungrow to showcase state-of-the-art solar and storage solutions at CLEANPOWER 2024
- Schaeffler Applauded by Frost & Sullivan for Offering Integrated Condition Monitoring and Smart Lubrication with Its OPTIME Ecosystem
- ATRenew to Attend Goldman Sachs TechNet Conference Asia Pacific 2024
- ICICI Bank enables NRI customers to use international mobile number to make UPI payments in India
- Read more
Health Care/Hospital Recent Releases
- Clarivate Introduces Epidemiology Intelligence™ for Precision Patient Population Analysis
- Sciwind Biosciences and HK inno.N Corporation Announce Licensing and Partnership Agreement for Ecnoglutide Injection (XW003) in South Korea
- 2024 World Brain Day Dedicated to Brain Health and Prevention
- GC Genome to Present New Clinical Data on Colorectal Cancer Detection at the ASCO Annual Meeting 2024
- Innovent Receives NMPA Breakthrough Therapy Designation for IBI343（Anti-Claudin18.2 ADC）as Monotherapy for Advanced Gastric Cancer
- Read more
Medical/Pharmaceuticals Recent Releases
- Sciwind Biosciences and HK inno.N Corporation Announce Licensing and Partnership Agreement for Ecnoglutide Injection (XW003) in South Korea
- 2024 World Brain Day Dedicated to Brain Health and Prevention
- GC Genome to Present New Clinical Data on Colorectal Cancer Detection at the ASCO Annual Meeting 2024
- The Adecco Group: Q1 2024 RESULTS
- Innovent Receives NMPA Breakthrough Therapy Designation for IBI343（Anti-Claudin18.2 ADC）as Monotherapy for Advanced Gastric Cancer
- Read more